Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_B3,1 | Lung | Primary cancer | 3,047 | Other | 28.4% | 0.42 | 0.93 |
| NSCLC_38242124__IMC__88_B3,10 | Lung | Primary cancer | 1,646 | Stromal | 41.4% | 0.76 | 0.54 |
| NSCLC_38242124__IMC__88_B3,11 | Lung | Primary cancer | 396 | Tumor/Malignant | 79.5% | 0.96 | 0.11 |
| NSCLC_38242124__IMC__88_B3,12 | Lung | Primary cancer | 2,461 | Tumor/Malignant | 62.6% | 0.98 | 0.12 |
| NSCLC_38242124__IMC__88_B3,13 | Lung | Primary cancer | 2,525 | Tumor/Malignant | 63.0% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__88_B3,14 | Lung | Primary cancer | 2,309 | Tumor/Malignant | 47.4% | 0.96 | 0.18 |
| NSCLC_38242124__IMC__88_B3,15 | Lung | Primary cancer | 3,583 | Tumor/Malignant | 60.0% | 0.94 | 0.19 |
| NSCLC_38242124__IMC__88_B3,16 | Lung | Primary cancer | 2,973 | Tumor/Malignant | 55.3% | 0.92 | 0.24 |
| NSCLC_38242124__IMC__88_B3,4 | Lung | Primary cancer | 5,405 | Stromal | 57.5% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__88_B3,5 | Lung | Primary cancer | 3,434 | Tumor/Malignant | 55.5% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__88_B3,6 | Lung | Primary cancer | 4,461 | Tumor/Malignant | 42.0% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__88_B3,7 | Lung | Primary cancer | 3,167 | Stromal | 37.3% | 0.76 | 0.51 |
| NSCLC_38242124__IMC__88_B3,8 | Lung | Primary cancer | 2,624 | Tumor/Malignant | 28.4% | 0.90 | 0.32 |
| NSCLC_38242124__IMC__88_B3,9 | Lung | Primary cancer | 2,779 | Tumor/Malignant | 35.9% | 1.00 | 0.06 |
| NSCLC_38242124__IMC__88_B4,1 | Lung | Primary cancer | 1,954 | Tumor/Malignant | 63.8% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__88_B4,10 | Lung | Primary cancer | 2,510 | Tumor/Malignant | 43.6% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__88_B4,11 | Lung | Primary cancer | 2,674 | Tumor/Malignant | 75.1% | 0.95 | 0.13 |
| NSCLC_38242124__IMC__88_B4,12 | Lung | Primary cancer | 2,865 | Tumor/Malignant | 43.5% | 0.94 | 0.21 |
| NSCLC_38242124__IMC__88_B4,14 | Lung | Primary cancer | 2,759 | Immune | 23.8% | 0.84 | 0.43 |
| NSCLC_38242124__IMC__88_B4,15 | Lung | Primary cancer | 4,974 | Tumor/Malignant | 80.4% | 0.98 | 0.08 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_B3,1 | Lung | Primary cancer | 3,047 | Stromal | 22.1% | 0.77 | 0.56 |
| NSCLC_38242124__IMC__88_B3,10 | Lung | Primary cancer | 1,646 | Stromal | 27.1% | 0.84 | 0.42 |
| NSCLC_38242124__IMC__88_B3,11 | Lung | Primary cancer | 396 | Tumor/Malignant | 80.6% | 0.96 | 0.11 |
| NSCLC_38242124__IMC__88_B3,12 | Lung | Primary cancer | 2,461 | Tumor/Malignant | 51.8% | 1.00 | 0.04 |
| NSCLC_38242124__IMC__88_B3,13 | Lung | Primary cancer | 2,525 | Tumor/Malignant | 51.0% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__88_B3,14 | Lung | Primary cancer | 2,309 | Tumor/Malignant | 48.8% | 0.94 | 0.21 |
| NSCLC_38242124__IMC__88_B3,15 | Lung | Primary cancer | 3,583 | Tumor/Malignant | 39.9% | 1.00 | 0.04 |
| NSCLC_38242124__IMC__88_B3,16 | Lung | Primary cancer | 2,973 | Tumor/Malignant | 51.8% | 0.94 | 0.21 |
| NSCLC_38242124__IMC__88_B3,4 | Lung | Primary cancer | 5,405 | Stromal | 57.2% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__88_B3,5 | Lung | Primary cancer | 3,434 | Tumor/Malignant | 52.1% | 0.95 | 0.15 |
| NSCLC_38242124__IMC__88_B3,6 | Lung | Primary cancer | 4,461 | Tumor/Malignant | 38.8% | 0.96 | 0.14 |
| NSCLC_38242124__IMC__88_B3,7 | Lung | Primary cancer | 3,167 | Stromal | 35.3% | 0.51 | 0.93 |
| NSCLC_38242124__IMC__88_B3,8 | Lung | Primary cancer | 2,624 | Tumor/Malignant | 23.2% | 0.95 | 0.22 |
| NSCLC_38242124__IMC__88_B3,9 | Lung | Primary cancer | 2,779 | Tumor/Malignant | 36.7% | 1.00 | 0.07 |
| NSCLC_38242124__IMC__88_B4,1 | Lung | Primary cancer | 1,954 | Tumor/Malignant | 57.4% | 0.99 | 0.09 |
| NSCLC_38242124__IMC__88_B4,10 | Lung | Primary cancer | 2,510 | Tumor/Malignant | 32.6% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__88_B4,11 | Lung | Primary cancer | 2,674 | Tumor/Malignant | 57.8% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__88_B4,12 | Lung | Primary cancer | 2,865 | Tumor/Malignant | 38.9% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__88_B4,14 | Lung | Primary cancer | 2,759 | Lymphoid | 22.0% | 0.74 | 0.64 |
| NSCLC_38242124__IMC__88_B4,15 | Lung | Primary cancer | 4,974 | Tumor/Malignant | 72.4% | 0.99 | 0.03 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_B3,1 | Lung | Primary cancer | 3,047 | Fibroblast | 28.0% | 0.65 | 0.77 |
| NSCLC_38242124__IMC__88_B3,10 | Lung | Primary cancer | 1,646 | Fibroblast | 34.4% | 0.76 | 0.56 |
| NSCLC_38242124__IMC__88_B3,11 | Lung | Primary cancer | 396 | Tumor/Malignant cell | 80.6% | 0.96 | 0.11 |
| NSCLC_38242124__IMC__88_B3,12 | Lung | Primary cancer | 2,461 | Tumor/Malignant cell | 62.5% | 0.98 | 0.12 |
| NSCLC_38242124__IMC__88_B3,13 | Lung | Primary cancer | 2,525 | Tumor/Malignant cell | 62.2% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__88_B3,14 | Lung | Primary cancer | 2,309 | Tumor/Malignant cell | 52.6% | 0.93 | 0.25 |
| NSCLC_38242124__IMC__88_B3,15 | Lung | Primary cancer | 3,583 | Tumor/Malignant cell | 60.7% | 0.94 | 0.20 |
| NSCLC_38242124__IMC__88_B3,16 | Lung | Primary cancer | 2,973 | Tumor/Malignant cell | 54.8% | 0.93 | 0.24 |
| NSCLC_38242124__IMC__88_B3,4 | Lung | Primary cancer | 5,405 | Fibroblast | 65.1% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__88_B3,5 | Lung | Primary cancer | 3,434 | Tumor/Malignant cell | 55.9% | 0.94 | 0.19 |
| NSCLC_38242124__IMC__88_B3,6 | Lung | Primary cancer | 4,461 | Tumor/Malignant cell | 43.0% | 0.94 | 0.20 |
| NSCLC_38242124__IMC__88_B3,7 | Lung | Primary cancer | 3,167 | Fibroblast | 31.5% | 0.76 | 0.62 |
| NSCLC_38242124__IMC__88_B3,8 | Lung | Primary cancer | 2,624 | Tumor/Malignant cell | 27.9% | 0.91 | 0.32 |
| NSCLC_38242124__IMC__88_B3,9 | Lung | Primary cancer | 2,779 | Tumor/Malignant cell | 59.4% | 0.94 | 0.23 |
| NSCLC_38242124__IMC__88_B4,1 | Lung | Primary cancer | 1,954 | Tumor/Malignant cell | 66.3% | 0.97 | 0.14 |
| NSCLC_38242124__IMC__88_B4,10 | Lung | Primary cancer | 2,510 | Tumor/Malignant cell | 47.8% | 0.95 | 0.21 |
| NSCLC_38242124__IMC__88_B4,11 | Lung | Primary cancer | 2,674 | Tumor/Malignant cell | 74.3% | 0.95 | 0.13 |
| NSCLC_38242124__IMC__88_B4,12 | Lung | Primary cancer | 2,865 | Tumor/Malignant cell | 43.4% | 0.94 | 0.21 |
| NSCLC_38242124__IMC__88_B4,14 | Lung | Primary cancer | 2,759 | B cell | 27.7% | 0.43 | 1.02 |
| NSCLC_38242124__IMC__88_B4,15 | Lung | Primary cancer | 4,974 | Tumor/Malignant cell | 80.4% | 0.98 | 0.08 |